Action CATX PERSPECTIVE THERAPEUTICS, INC.
Ajouter à une liste
Pour utiliser cette fonction vous devez être client ou membre
ConnexionInscription

Autres langues Perspective Therapeutics, Inc.

Actions

CATX

US46489V3024

Marché Fermé - Nyse
Autres places de cotation
 22:00:00 21/06/2024 		Varia. 5j. Varia. 1 janv.
10,09 USD -5,26% Graphique intraday de Perspective Therapeutics, Inc. +842,99% +151,00%
12/06 Mise à jour sectorielle : Les actions du secteur de la santé ralentissent en fin d'après-midi MT
12/06 Mise à jour sectorielle : Les actions du secteur de la santé sont plus molles mercredi après-midi MT

Autres langues

Recherche
Voir les résultats
Débloquez toutes les actualités : Soyez le premier informé et réagissez avant les marchés !
Inscription 100% Gratuite
Sector Update: Health Care Stocks Ease Late Afternoon
Sector Update: Health Care Stocks Softer Wednesday Afternoon
Perspective Therapeutics to Join Russell 3000 Index on July 1
Perspective Therapeutics Announces Inclusion in the Russell 3000® Index
Perspective Therapeutics to Reverse Split Common Shares
Perspective Therapeutics Announces 1-for-10 Reverse Stock Split
Perspective Therapeutics Announces 1-for-10 Reverse Stock Split
Perspective Therapeutics Presents at the Society of Nuclear Medicine and Molecular Imaging 2024 Annual Meeting
Perspective Therapeutics Prices $80 Million Share, Warrant Offering
Perspective Therapeutics Announces Pricing of $80 Million Underwritten Offering of Common Stock and Pre-Funded Warrants
Perspective Therapeutics to Present at the Society of Nuclear Medicine and Molecular Imaging Annual Meeting 2024
Perspective Therapeutics to Present at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) Annual Meeting 2024
Perspective Therapeutics Swings to Loss in Q1, Revenue Rises
Perspective Therapeutics Provides Recent Business Highlights and Reports Fiscal Q1 2024 Results
Perspective Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
Perspective Therapeutics to Participate at Upcoming May Investor Conferences
Perspective Therapeutics to Participate at Upcoming May Investor Conferences
Perspective Therapeutics to Provide Recent Business Highlights and Report First Quarter 2024 Financial Results
Perspective Therapeutics Selected by FDA to Participate in the CDRP Program to Expedite Chemistry, Manufacturing, and Controls Development Readiness for VMT-α-NET in NETs
Perspective Therapeutics Selected by FDA to Participate in the CDRP Program to Expedite Chemistry, Manufacturing, and Controls Development Readiness for VMT-α-NET in NETs
Aucun résultat pour cette recherche
Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Rechercher

Date de publication

Depuis le

Jusqu'au

  1. Bourse
  2. Actions
  3. Action CATX
  4. Actualités Perspective Therapeutics, Inc.
  5. Autres langues